Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Mira Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 16.50 and a low estimate of 7.50. The median estimate represents a 848.28% increase from the last price of 1.16.
High | 1,322.4% | 16.50 |
Med | 848.3% | 11.00 |
Low | 546.6% | 7.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 21, 2024.
Average growth rate | +31.09% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼